The Scottish Investment Bank is the investment arm of Scottish Enterprise.
Portfolio
31
companies
Administrate
Administrate builds software to automate and manage training and learning delivery.
Agency Core
Agency Core builds business management software for creative agencies.
Aurum Biosciences
Aurum Biosciences develops novel oxygen carriers and diagnostic software for clinical use.
Bio-Images Drug Delivery
Bio-Images Drug Delivery develops precision timed drug release technology for pharmaceutical treatments.
Calcivis
Edinburgh biotechnology firm developing tools for the early detection and prevention of tooth decay.
Clear Returns
Clear Returns provides predictive analytics to help retailers reduce product returns and protect profit margins.
ClinSpec Diagnostics
ClinSpec Diagnostics develops rapid liquid biopsies for early cancer detection.
ClinSpec Dx
ClinSpec Dx develops blood test technology for the early detection of cancer.
Clyde Biosciences
Clyde Biosciences develops technology to evaluate drug toxicity.
Current Health
Enterprise remote care management platform for home-based patient monitoring.
Epipole
Epipole develops handheld retinal imaging devices for clinical use.
GSi
GSi processes satellite data and machine learning analytics to monitor global environmental and commercial metrics.
GeckoLabs
GeckoLabs provides engagement and recruitment software for universities.
Good-Loop
Good-Loop connects brand advertising campaigns with charitable giving and carbon reduction.
Intelligent Growth Solutions
Intelligent Growth Solutions develops indoor vertical farming and commercial lighting systems.
Invizius
Invizius develops treatments to prevent life threatening inflammation during dialysis.
MGB Biopharma
MGB Biopharma develops a novel class of anti-infectives to tackle antibiotic resistance.
MIME Technologies
Mime Technologies develops in-flight medical monitoring systems for commercial aviation.
Macomics
Macomics develops novel immuno-therapies to overcome resistance in cancer treatments.
MiAlgae
MiAlgae develops biotechnology to create sustainable Omega 3 from industry coproducts.
Mocean Energy
Mocean Energy develops wave energy technology to supply low-carbon power for marine environments.
Novel Technologies Holdings
Novel Technologies Holdings develops permanent silver-based antimicrobial treatments for textiles and surfaces.
Quorum Cyber
Quorum Cyber provides professional and managed security services to protect organisations against cyber attacks and data breaches.
Reactec
Reactec provides workplace health monitoring and data analytics technology for industrial workers.
Sofant
Sofant builds radio frequency components and smart antenna solutions for wireless and satellite applications.
Sofant Technologies
Sofant Technologies develops low-power RF MEMS beamforming solutions for satellite communications.
Sustainable Marine Energy
Sustainable Marine Energy develops tidal energy platform systems.
Swipii
Swipii provides a card-linked loyalty application for retail customers and merchants.
Trojan Energy
Trojan Energy manufactures flush street-level charging points for electric vehicles.
iMetafilm
Digital archive technology provider making historical film footage searchable.
pureLiFi
PureLiFi develops optical wireless technology that transmits data through light.
Kerry Sharp
Director
Kerry brings investment, finance, and economic development experience from roles at Scottish Enterprise, the Scottish Investment Bank, and Funding London.
LinkedInThe Edinburgh firm secured backing led by Equity Gap alongside an Innovate UK grant to accelerate commercialisation of its Blue Star wave machine.
"Our goal is to produce a commercially-available wave machine which can deliver low carbon power for tie backs and future fleets of autonomous AUVs [autonomous underwater vehicles]"
The financing round was backed by Infinion Biopharma, the Scottish Investment Bank, Scottish Health Innovations, and TRICAPITAL.
"We are delighted to complete this second round with our initial investment partners and bringing in a new investment partner, Infinion. This funding will allow us to extend our work beyond the successfully completed pre-clinical trials where Aurum’s lead product has demonstrated great potential in both stroke treatment and diagnosis. We are especially pleased that Infinion have joined the investment and look forward to them helping to drive Aurum forward with their global expertise in the biopharma sector. There has been few new therapies or diagnostics approved for acute ischaemic stroke in recent years. Our products provide hope for the many patients, carers and healthcare professionals who live with the consequences of this devastating condition."
The funding round was led by Mercia EIS Funds alongside several institutional backers.
The funding round was led by Mercia and will support the firm in progressing its multi-cancer diagnostic programmes.
"Worldwide, 26,000 people die from cancer each day. Early detection is critical for effective treatment, but many cancers go undetected for too long. This funding is another significant step forward for ClinSpec Dx in our mission to detect cancer earlier and help to increase patient survival and quality of life."
EMV Capital led the pre-series A round to support product development and partnership activities in 5G and satellite communications.
"We are very pleased to have supportive investors who understand the value of semiconductor-based hardware. This funding will be used to complete the development of our core RF technology platform. It will also support our activities with an ecosystem of corporate partners who share Sofant’s belief that RF MEMS will disrupt the market for high frequency SatCom and 5G antenna applications. It is a very exciting time for Sofant, and we look forward to working with our partners to change the way high frequency antenna systems are designed and built."
